Multiple System Atrophy: a rare Parkinsonsim
Multiple System Atrophy (MSA) is a rare neurological (brain) condition caused by a gradual loss and shrinkage of brain cells. This loss of cells occurs in the parts of the brain that control movement, balance and automatic functions of the body such as bladder and blood pressure.
To better understand the biology of MSA.
Multiple - many (parts of the brain)
System - the brain structures that control different functions
Atrophy - cell shrinkage or damage
Treatments and therapies are available to help manage symptoms of MSA, however there is no cure or ways to prevent it from occurring or slow its progression.
Other terms sometimes used to describe MSA are ‘olivopontocerebellar atrophy’, ‘striatonigral degeneration’, ‘Parkinson’s plus’ and ‘Shy-Drager Syndrome’.
Understanding the biology of MSA may give us a better understanding of neurodegenerative diseases.
The project will involve working with human brain bank material, mouse models of the disease and cell culture.
Latest Florey news for Parkinson’s disease
Current & emerging treatments for Parkinson’s disease: from bedside to bench
In 2014, conservative estimates indicated there were just under 70,000 people living with Parkinson’s in Australia making it the most common major movement disorder and second highest prevalence neurodegenerative condition with only dementia exceeding it.
Parkinson’s research accelerates thanks to Argyrou family grant
Dr Dominic Hare and his world class team from the worlds of chemistry, physics, neuroscience and pathology, have won the 2018 Argyrou Family Fellowship
Brain health affects all Australians. You can support our research by making a donation or a bequest.